SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-10-072527
Filing Date
2010-08-04
Accepted
2010-08-04 16:37:55
Documents
9
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f56297e10vq.htm 10-Q 467033
2 EX-31.1 f56297exv31w1.htm EX-31.1 7136
3 EX-31.2 f56297exv31w2.htm EX-31.2 7447
4 EX-32.1 f56297exv32w1.htm EX-32.1 5194
  Complete submission text file 0000950123-10-072527.txt   2121319

Data Files

Seq Description Document Type Size
5 EX-101 INSTANCE DOCUMENT onxx-20100630.xml EX-101.INS 268165
6 EX-101 SCHEMA DOCUMENT onxx-20100630.xsd EX-101.SCH 14004
7 EX-101 CALCULATION LINKBASE DOCUMENT onxx-20100630_cal.xml EX-101.CAL 38322
8 EX-101 LABELS LINKBASE DOCUMENT onxx-20100630_lab.xml EX-101.LAB 125357
9 EX-101 PRESENTATION LINKBASE DOCUMENT onxx-20100630_pre.xml EX-101.PRE 71869
Mailing Address 2100 POWELL STREET EMERYVILLE CA 94608
Business Address 2100 POWELL STREET EMERYVILLE CA 94608 5105976500
ONYX PHARMACEUTICALS INC (Filer) CIK: 0001012140 (see all company filings)

IRS No.: 943154463 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-28298 | Film No.: 10991514
SIC: 2836 Biological Products, (No Diagnostic Substances)